Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Der Urologe. Ausg. A|November 19, 2003
[Immunotherapy of renal cell carcinoma. With special emphasis on therapy of the elderly patient]H Heinzer, E Huland, H HulandAnticancer Research|September 2, 1999
Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2)E Huland, H Heinzer, H HulandHepato-Gastroenterology|August 3, 1999
Immunotherapy of pulmonary metastatic renal cell carcinoma: success dependant on risk factors?E Huland, H Heinzer, H HulandWorld Journal of Urology|May 26, 2001
Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancerH Heinzer, E Huland, H HulandDer Urologe. Ausg. A|March 8, 2014
[Alpha emitter radium-223 dichloride: new therapy in castration-resistant prostate cancer with symptomatic bone metastases]H Heinzer, F König, S KlutmannDer Urologe. Ausg. A|August 25, 2000
[Treatment of metastatic renal cell carcinoma. Value of immunotherapy compared with surgery of metastases]H Heinzer, E Huland, H HulandThe Journal of Urology|February 1, 1992
Interleukin-2 by inhalation: local therapy for metastatic renal cell carcinomaE Huland, H Huland, H HeinzerDer Urologe. Ausg. A|July 23, 2002
[Regional immunotherapy of metastatic renal cell carcinoma]H Heinzer, E Huland, H HulandFolia Biologica|January 5, 2001
A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinomaE Huland, H Heinzer, H HulandJournal of Cancer Research and Clinical Oncology|January 1, 1994
Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatmentE Huland, H Heinzer, H HulandPageof 5